2. β’ A 35 year lady presented with alleged h/o consumption of Amlokind AT (Amlodipine 2.5mg
+ Atenolol 25mg) 4 tablets (total dose being amlodipine β 10mg and atenolol β 200mg ) on
13/3/23 at 9.30am
β’ Giddiness and chest pain since then.
CHIEF COMPLAINT
3. β’ Patient has come with alleged h/o consumption of Amlokind AT (Amlodipine 2.5mg +
Atenolol 25mg) 4 tablets on 13/3/23 at 9.30am
β’ Giddiness and chest pain since then
β’ Duration between incident and hospital admission β 1 and half hour
β’ No history of vomitings/seizures
β’ No h/o LOC
β’ No h/o coingestions
β’ No comorbidities
β’ No h/o psychiatric illness
β’ No h/o drug abuse
β’ No h/o prior hospital admissions.
History of present illness
4. ON EXAMINATION- DAY1 IN ICU
ο AIRWAY β Patent
ο BREATHING β Spontaneously at room air
οCIRCULATION β Warm peripheries
Screening echo β Normal LV function. No RA/RV dilatation.
5. ο GENERAL EXAMINATION β No pallor,icterus,clubbing,cyanosis,lymphadenopathy,edema
HR-37/min , BP- 110/50mmhg,
ο CARDIOVASCULAR SYSTEM - S1S2 heard, No murmurs heard
ο Neurological system β GCS- E3VTM6
Pupils- B/L 2mm, Reacting to light
Power β 5/5 in all limbs
ο RESPIRATORY SYSTEM β BAE heard. No abnormal sounds heard.
ο ABDOMINAL β Soft
No organomegaly
BS β present
6. DAY 1
β’ Gastric lavage
β’ Activated charcoal
β’ Mobitz type II block
β’ 1 dose of atropine
β’ Glucagon
β’ Calcium gluconate
β’ Isoprenaline infusion